Following eyonis® LCS' FDA 510 (k) clearance announced on February 9, 2026, Median has activated a phased U.S. launch strategy designed for disciplined national expansion. The Company has conducted ...

Low-dose computed tomography (LDCT) screening is effective in reducing lung cancer mortality by detecting the disease at earlier, more treatable stages. However, high false-positive rates and the ...

The US Food and Drug Administration (FDA) has granted marketing clearance to Eyonis LCS, an artificial intelligence-powered software program to assist with lung cancer screening.

Colorectal cancer is the second leading cause of cancer-related deaths for males and females. Screening for colorectal cancer is an effective strategy to reduce morbidity and mortality. The ...

Forbes contributors publish independent expert analyses and insights. A physician who writes about challenges with navigating healthcare. And while colonoscopy remains the gold standard for prevention ...

Lung cancer screening has the potential to catch lung cancer early and save lives -- but only if people get screened. Although lung cancer screening is recommended in the U.S. for certain individuals ...

Adamson is a dermatologist and health disparities researcher at Dell Medical School. Patel is a resident physician at Brigham and Women’s Hospital in Boston. Welch is a general internist at Brigham ...

Colorectal cancer was once considered primarily a disease of aging. But rates are now on the rise among younger adults. Since 2011, colon cancer rates among people younger than 50 have increased by ...

Two new modeling studies suggest that expanding lung cancer screening — to include more smokers or even lifelong nonsmokers — would save thousands more lives in the US every year. But not everyone is ...